Hong Kong wealth fund backs homegrown surgical robotics start-up to boost biotech drive
Cornerstone Robotics receives US$200 million injection from Hong Kong government’s investment arm and major venture capital firms

Cornerstone Robotics founder and CEO Samuel Au Kwok-wai said HKIC’s investment reflected the government’s commitment to support local innovative enterprises to go global.

Founded in 2019, Cornerstone Robotics began a clinical trial in Hong Kong three years ago before expanding to hospitals in mainland China.
Robotic surgical systems help surgeons perform minimally invasive procedures with the use of magnification and tiny, robotically controlled tools. Such systems are sometimes controlled remotely.
In addition to HKIC, the latest round of fundraising included other major venture capital firms like Qiming Venture Partners, Gaorong Ventures and Bridgeone Capital, the start-up said.